Alex Harding

Alex Harding

Corporate Officer/Principal chez CRISPR THERAPEUTICS AG

Consumer Services
Health Technology
Finance

Profil

Alex Harding is currently the Head of Business Development and Senior Vice President at CRISPR Therapeutics AG since 2023.
Prior to this, he worked as an Associate at Atlas Venture Advisors, Inc. from 2018 to 2019.
He also held the position of Senior Vice President of Business Development at Remix Therapeutics, Inc. Dr. Harding completed his Doctorate degree from The Johns Hopkins University in 2015, his Undergraduate degree from Yale University in 2014, and his MBA from Harvard Business School in 2014.

Postes actifs de Alex Harding

SociétésPosteDébut
CRISPR THERAPEUTICS AG Corporate Officer/Principal 05/01/2023
Tous les postes actifs de Alex Harding

Anciens postes connus de Alex Harding

SociétésPosteFin
Analyste en capital-investissement 31/12/2019
Corporate Officer/Principal -
Voir l'expérience en détail de Alex Harding

Formation de Alex Harding

Harvard Business School Masters Business Admin
Yale University Undergraduate Degree
The Johns Hopkins University Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Alex Harding

Relations

100 +

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
CRISPR THERAPEUTICS AG

Health Technology

Entreprise privées2

Finance

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Alex Harding